Journal Masthead

Matrix Medical Communications
1595 Paoli Pike
Suite 201
West Chester, PA 19380
Toll-free (866) 325-9907
Phone (484) 266-0702
Fax (484) 266-0726
Send Email

 


EDITORIAL STAFF

Editor

Amir H. Kalali, MD
Professor of Psychiatry
University of California
San Diego, California
 

Executive Editor
Elizabeth A. Klumpp
Matrix Medical Communications
West Chester, Pennsylvania

 

Managing Editor
Angela M. Saba
Matrix Medical Communications
West Chester, Pennsylvania

 

Assistant Editor
Julia E. Eckert
Matrix Medical Communications
West Chester, Pennsylvania

 

Assistant Editor
Frank Hosking III
Matrix Medical Communications
West Chester, Pennsylvania

 

Assistant Editor
Austin K. Vitelli
Matrix Medical Communications
West Chester, Pennsylvania

 


 

BUSINESS STAFF

 

President/Group Publisher
Robert L. Dougherty
Matrix Medical Communications
West Chester, Pennsylvania

 

Vice President, Publisher
Joseph J. Morris
Matrix Medical Communications
West Chester, Pennsylvania

 

Vice President, Editorial Director
Elizabeth A. Klumpp
Matrix Medical Communications
West Chester, Pennsylvania

 

Vice President, Business Development and Finance
Christine C. Franey
Matrix Medical Communications
West Chester, Pennsylvania

 

Associate Director of Business Development
Christopher Moccia
Matrix Medical Communications
West Chester, Pennsylvania

 

Social Media and Grants Coordinator
Emily A. Scullin
Matrix Medical Communications
West Chester, Pennsylvania

 

Partner
Patrick D. Scullin
Matrix Medical Communications
West Chester, Pennsylvania

 


 

Innovations in Clinical Neuroscience, ISSN 2158-8333 (Print) and ISSN 2158-8341(Online), is published electronically 6 times yearly by Matrix Medical Communications via www.innovationscns.com. To receive an e-mail when a new issue is available and/or to access full content online, complete the online registration form. Registration and access are free to qualified professionals. Innovations in Clinical Neuroscience is not intended for patients or consumers.

Copyright © 2018 Matrix Medical Communications. All rights reserved. Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of Matrix Medical Communications, the editorial staff, or any member of the editorial advisory board. Matrix Medical Communications is not responsible for accuracy of dosages given in the articles printed herein. The appearance of advertisements in this journal is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. Matrix Medical Communications disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.

VOLUME 15, ISSUE 5–6, MAY–JUNE 2018

Editorial Message and Issue Highlights–Vol. 15, No. 5–6, May-June 2018

Editorial Message and Issue Highlights–Vol. 15, No. 5–6, May-June 2018

Dear Colleagues: Welcome to the May–June 2018 issue of Innovations in Clinical Neuroscience (ICNS). We start the issue with a timely review article by Touma and Scarff titled, “Valbenazine and Deutetrabenazine for Tardive Dyskinesia (TD).” Here, the authors discuss the two drugs, which were recently approved by the United States Food and Drug Administration (FDA) […]

Continue Reading

Atrial Fibrillation and Injected Aripiprazole: A Case Report

Atrial Fibrillation and Injected Aripiprazole: A Case Report

by Anthi Stefatos, MD; Julie N. Ha, PharmD; Adrian Baranchuk MD; Ross J. Baldessarini, MD; and Gustavo H. Vázquez MD, PhD Drs. Stefatos and Ha are with the Department of Psychiatry at Queens University in Kingston, Ontario, Canada. Dr. Baranchuk is with the Department of Medicine at Queens University in Kingston, Ontario, Canada. Dr. Baldessarini […]

Continue Reading

Development of a Behavioral Health Stigma Measure and Application of Machine Learning for Classification

Development of a Behavioral Health Stigma Measure and Application of Machine Learning for Classification

by Farah Tokmic, PhD; Mirsad Hadzikadic, PhD; James R. Cook, PhD; and Oleg V. Tcheremissine, MD Drs. Tokmic and Hadzikadic are with the Department of Software & Information Systems at the University of North Carolina, in Charlotte, North Carolina. Dr. Cook is with the Department of Psychology at the University of North Carolina, in Charlotte, […]

Continue Reading

Delirium and Psychotic Symptoms Associated with Hyperglycemia in a Patient with Poorly controlled Type 2 Diabetes Mellitus

Delirium and Psychotic Symptoms Associated with Hyperglycemia in a Patient with Poorly controlled Type 2 Diabetes Mellitus

by Rui Lopes, MD, and Bernardo Dias Pereira, MD Dr. Lopes is with the Faculty of Medicine at the University of Porto in Porto, Portugal. Dr. Pereira is with the Department of Endocrinology and Nutrition at the Hospital do Divino Espírito Santo de Ponta Delgada in Azores, Portugal, and the Pre-clinical Section of the Medicine […]

Continue Reading

Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two Randomized, Placebo-controlled Trials

Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two Randomized, Placebo-controlled Trials

by David V. Sheehan, MD, MBA; Maria Gasior, MD, PhD; Susan L. McElroy, MD; Jana Radewonuk, MSc; Barry K. Herman, MD, MMM; and James Hudson, MD, ScD Dr. Sheehan is with the University of South Florida College of Medicine in Tampa, Florida. Drs. Herman and Gasior and Ms. Radewonuk are formerly affiliated with Shire Pharmaceuticals […]

Continue Reading

Combination Phentermine–Topiramate Extended Release for the Treatment of Binge Eating Disorder: An Open-Label, Prospective Study

Combination Phentermine–Topiramate Extended Release for the Treatment of Binge Eating Disorder: An Open-Label, Prospective Study

by Anna I. Guerdjikova, PhD, LISW; Stephanie Williams, MS; Thomas J. Blom, MS; Nicole Mori, CNP; and Susan L. McElroy, MD Drs. Guerdjikova and McElroy and Ms. Mori are with the Lindner Center of HOPE in Mason, Ohio, and the Department of Psychiatry and Behavioral Neuroscience at the University of Cincinnati College of Medicine in […]

Continue Reading

PAST ARTICLES (user login required)

Editorial Message and Issue Highlights–Vol. 15, No. 3–4, March-April 2018

Editorial Message and Issue Highlights–Vol. 15, No. 3–4, March-April 2018

Continue Reading

Neuroscience is the Next Oncology

Neuroscience is the Next Oncology

by Michael D. Ehlers, MD, PhD Dr. Ehlers is with Biogen in Cambridge, Massachusetts. Innov Clin Neurosci. 2018;15(3–4):15–16 Funding: No funding was received for the preparation of this article. Disclosures: Dr. Ehlers is an employee and shareholder at Biogen Inc. in Cambridge, Massachusetts.

Continue Reading

Modafinil for the Improvement of Patient Outcomes Following Traumatic Brain Injury

Modafinil for the Improvement of Patient Outcomes Following Traumatic Brain Injury

by Amne Borghol, PharmD, BCPS, BCGP; Michael Aucoin, PharmD; Ifeanyichukwu Onor, PharmD, BCPS; Dana Jamero, PharmD, BCOP; and Fadi Hawawini, DO, CMD  Drs. Borghol, Onor, and Jamero are with the College of Pharmacy at Xavier University of Louisiana in New Orleans, Louisiana. Dr. Aucoin is with the Woman’s Hospital in Baton Rouge, Louisiana. Dr. Hawawini […]

Continue Reading

Effects of Statins and Cholesterol on Patient Aggression: Is There a Connection?

Effects of Statins and Cholesterol on Patient Aggression: Is There a Connection?

by Emily Leppien, PharmD, BCPS; Kimberly Mulcahy, PharmD, BCPS, BCPP; Tammie Lee Demler, BS, PharmD, MBA, BCGP, BCPP; Eileen Trigoboff, RN, PMHCNS-BC, DNS, DABFN; and Lewis Opler, MD, PhD Drs. Leppien, Mulcahy, Demler, and Trigoboff are with Buffalo Psychiatric Center, New York State Office of Mental Health, and State University of New York, University at Buffalo […]

Continue Reading

Comorbid Insomnia and Psychiatric Disorders: An Update

Comorbid Insomnia and Psychiatric Disorders: An Update

by Khurshid A. Khurshid, MD, FAASM Dr. Khurshid is Clinical Associate Profressor and Chief of the Neuromodulation and Sleep Disorders Program in the Department of Psychiatry at the University of Florida College of Medicine in Gainsville, Florida. Innov Clin Neurosci. 2018;15(3–4):28–32 Funding: No funding was received for the preparation of this article. Disclosures: The author […]

Continue Reading

Psychosis in a Child with Atypical Autism: A Case Report and a Brief Review of the Association of Psychosis and Autism

Psychosis in a Child with Atypical Autism: A Case Report and a Brief Review of the Association of Psychosis and Autism

by Swapnajeet Sahoo, MD; Susanta Kumar Padhy, MD; Neha Singla, MD; and Aakanksha Singh, MD Drs. Sahoo, Singla, and Singh are Senior Residents and Dr. Padhy is Associate Professor in the Department of Psychiatry at the Post Graduate Institute of Medical Education and Research in Chandigarh, India.  Innov Clin Neurosci. 2018;15(3–4):33–36 Funding: The authors have […]

Continue Reading

THE NEUROSCIENCE REPORT

The Neuroscience Report—Vol. 53 (August 14, 2018): Binge Eating Disorders

The Neuroscience Report—Vol. 53 (August 14, 2018): Binge Eating Disorders

Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information.   This week’s topic: Binge Eating Disorder   5 Journal Articles Binge eating, trauma, and suicide attempt in community […]

Continue Reading

The Neuroscience Report—Vol. 52 (April 11, 2018): Migraines

The Neuroscience Report—Vol. 52 (April 11, 2018): Migraines

Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. This week’s topic: Migraines 5 Journal Articles Spotlight on Anti-CGRP monoclonal antibodies in migraine: the clinical evidence to date […]

Continue Reading

The Neuroscience Report—Vol. 51 (December 28, 2017): New Discoveries in Neurodegenerative Diseases

The Neuroscience Report—Vol. 51 (December 28, 2017): New Discoveries in Neurodegenerative Diseases

Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. This week’s topic: Discoveries in Neurodegenerative Diseases 5 Journal Articles Pathogenesis and […]

Continue Reading

The Neuroscience Report—Vol. 50 (December 20, 2017): Advances in Neuroscience

The Neuroscience Report—Vol. 50 (December 20, 2017): Advances in Neuroscience

The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. This week’s topic: Advances […]

Continue Reading

The Neuroscience Report—Vol. 49 (December 11, 2017): Neurological Disorders

The Neuroscience Report—Vol. 49 (December 11, 2017): Neurological Disorders

The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. This week’s topic: Neurological […]

Continue Reading

The Neuroscience Report—Vol. 48 (November 30, 2017): Multiple Sclerosis

The Neuroscience Report—Vol. 48 (November 30, 2017): Multiple Sclerosis

The latest in neuroscience—sorted and summarized for you Welcome to The Neuroscience Report where each week we will highlight a specific topic in neuroscience and provide you with links to 5 journal articles, 5 news articles, and 5 wildcard picks. Brought to you by Innovations in Clinical Neuroscience—your source for peer-reviewed, evidence-based information. This week’s topic: Multiple […]

Continue Reading

SPECIAL ISSUES AND SUPPLEMENTS

Hot Topics in Multiple Sclerosis

Hot Topics in Multiple Sclerosis

Click the cover below to access the digital editions of Hot Topics in Multiple Sclerosis! June 2018 March 2018 December 2017 November 2017

Continue Reading

CNS Summit 2017 Abstracts of Poster Presentations

CNS Summit 2017 Abstracts of Poster Presentations

Innov Clin Neurosci. 2017;14(11–12)S1—S20

Continue Reading

Hot Topics in Pain Management

Hot Topics in Pain Management

Click the cover below to access the digital editions of Hot Topics in Pain Management! October 2017 September 2017 August 2017 July 2017

Continue Reading

CNS Summit 2016 Abstracts of Poster Presentations

CNS Summit 2016 Abstracts of Poster Presentations

Innov Clin Neurosci. 2017;14(1–2)3–23 A MESSAGE FROM THE EDITOR Dear Colleagues: Welcome to the annual CNS Summit Abstracts of Poster Presentations supplement to Innovations in Clinical Neuroscience. We are pleased to provide you with this reference guide to some of the innovative research that was presented during CNS Summit 2016, which was held October 27 […]

Continue Reading

Supplement to November–December 2015 Issue: Abstracts of Poster Presentations: CNS Summit 2015

Supplement to November–December 2015 Issue: Abstracts of Poster Presentations: CNS Summit 2015

October 7–11, 2015 Boca Raton, Florida Innov Clin Neurosci. 2015;12(11–12 Suppl C):3–17 CNS Drug Compounds Synthesis of carnitine analogues for inhibition of carnitine palmitoyltransferase Presenters: Bornstein J, Garneau-Tsodikova S Affiliations: University of Michigan Life Sciences Institute Background: Type 2 diabetes (T2DM) carries a markedly elevated risk of cerebrovascular disease. Carnitine plays a key role transporting […]

Continue Reading

Supplement to May–June 2015 Issue: CNS Summit 2014 Abstracts of Poster Presentations

Supplement to May–June 2015 Issue: CNS Summit 2014 Abstracts of Poster Presentations

Innov Clin Neurosci. 2015;12(5–6 Suppl B):3–19 CNS Drug Compounds/Therapies/Devices Long-acting injectable antipsychotics (LAIs) in outpatient treatment of DMS-IV-R schizophrenia Presenters: Bellnier T, Patil K, Ortega T, Seeger G Affiliations: SUNY University at Buffalo, GPI Clinical Research Background: The treatment of schizophrenia with LAIs is a significant focus of drug development. The cost of re-hospitalization due […]

Continue Reading

Recent Posts

Valbenazine and Deutetrabenazine  for Tardive Dyskinesia

Valbenazine and Deutetrabenazine for Tardive Dyskinesia

| May 1, 2018 | 0 Comments

by Katie T. B. Touma, PharmD, BCPP, BCPS, and Jonathan R. Scarff, MD Dr. Touma is with the William Jennings Bryan Dorn VA Medical Center Community-based Outpatient Clinic in Anderson, South Carolina. Dr. Scarff is with the Department of Behavioral Health at Kenner Army Health Clinic in Fort Lee, Virginia. Innov Clin Neurosci. 2018;15(5–6):13–16 Funding: […]

Continue Reading

Risk Management: Lessons to Be Learned: A Review of Post-suicide Malpractice Lawsuits

Risk Management: Lessons to Be Learned: A Review of Post-suicide Malpractice Lawsuits

| May 1, 2018 | 0 Comments

by Ann Mcnary, JD Ms. McNary is Senior Risk Manager at PRMS, Inc. in Arlington, Virginia. Funding: No funding was provided for the preparation of this article. Disclosures: Ms. McNary is an employee at PRMS, Inc. This ongoing column is dedicated to providing information to our readers on managing legal risks associated with medical practice. […]

Continue Reading

Letter to the Editor: Effective Pain Control in Hutchinson-Gilford Progeria Syndrome

Letter to the Editor: Effective Pain Control in Hutchinson-Gilford Progeria Syndrome

| May 1, 2018 | 0 Comments

Innov Clin Neurosci. 2018;15(5–6):11–12 Dr. Majeed is an attending psychiatrist with Department of Psychiatry, Natchaug Hospital in Norwich, Connecticut. Dr. Ubaidulhaq is a Pain Medicine Fellow and Dr. Gusa Attending Physician with the Department of Anesthesiology at the University of Mississippi Medical Center in Jackson, Mississippi. Funding/financial disclosures. The authors have no conflicts of interest […]

Continue Reading

Letter to the Editor: Kratom and the Opioid Crisis

Letter to the Editor: Kratom and the Opioid Crisis

| May 1, 2018 | 0 Comments

Innov Clin Neurosci. 2018;15(5–6):11–12 Dr. Bestha is with the Carolinas Healthcare System in Charlotte, North Carolina. Funding/financial disclosures. The author has no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Dear Editor: On October 26, 2017, the opioid crisis was declared a public […]

Continue Reading